OWN reveals more than 4.4 million doses of COVID vaccine in 9 countries
Many countries around the world have approved the COVID-19 vaccine by the Ministry of Higher Education, Science, Research and Innovation, and approximately nine countries have already used over 4.4 million doses of the human-tested vaccine, especially the state. It is said that 1.94 million doses in Thailand have reserved 26 million doses and the government is working on more to get more vaccines to meet everyone.
Professor Sirirerk Songsivilai, Permanent Secretary of the Ministry of Higher Education, Science, Research and Innovation (EW) revealed the progress of the research and development of the COVID-19 vaccine. That there is currently a COVID-19 vaccine Many species are tested in humans to ensure they are effective and safe enough. And has been approved in many countries around the world It has been used in approximately nine countries, including more than 4.4 million doses, in particular in the United States, the first inoculation of the population was initiated on December 14, 2020, with over 1.94 million doses of vaccine allocated. of 5.1 million doses of Pfizer / BioNtech and 6 million doses of Moderna vaccine, both of which must be administered in two doses each.The test results are effective in preventing COVID-19. More than 95 percent
With respect to the vaccine procurement and preparation, countries around the world have agreed to pre-book 8,150 million doses from each manufacturer, covering about half of the world population. With most of the vaccine being given 2 doses per person, the vaccine has already been booked for 4,075 million people, and deliveries started from now until 2022. AstraZeneca was the first company. That reached an advance vaccine subscription agreement for the world population Which currently has the most bookings This equates to approximately 1,460 million people, more than twice the number of third-party vaccines, while some are not tested, such as the Australian vaccine that had to cancel testing on December 10, 2020, and later Sanofi and GlaxoSmithKline. Also announced delaying vaccine testing
COVID-19 vaccine Is coming to market at record speed Usually vaccine development takes years. This is because the world has supported the accelerated research and development of multiple vaccines simultaneously and shortened the splicing time during each stage of testing, manufacturing and registration. Professor Siriruek Provide additional information that The number of vaccines being evaluated for efficacy is increasing. And each manufacturer has increased the number of production rapidly. Sufficient vaccines are expected for high-risk groups by early next year. And in the second half of 2021, most people who should be immunized will have access to this vaccine.
Professor Siriruek It said there were various approaches to vaccine strategies for each country, such as by means of bilateral agreements with individual manufacturers. Or as dozens of countries have multilateral agreements through the COVAX mechanism or through the World Health Organization? To ensure that the vaccine is distributed evenly However, the number of pre-orders for vaccines varies from country to country.For example, Canada, which has 38 million people, has vaccination contracts with at least seven companies to supply enough vaccines to inject 112 million people, three times the country’s population. Many times Including the UK, Australia, the United States, France, Italy, Japan, Mexico have already ordered more vaccines than the population. While other countries Around 0-20% of the population has been reserved for vaccines in Thailand, 26 million doses have been reserved, and the government is working on more to get more vaccines available to everyone. Both by domestic production Procured from each manufacturer And research and develop vaccines in the country as well
“RAIS has closely monitored the vaccine situation every day by coordinating with the CRC and the Ministry of Public Health. Oversee technical support, research and technology for vaccine production. And this unprecedented rapid development of the global novel coronavirus vaccine. It is very gratifying. Each vaccine that is evaluated Good performance Tested, it is safe. Can stimulate the immune system And prevent infection well Including researchers around the world to monitor the epidemic situation. Mutation And will develop various vaccines To be able to continue to improve efficiency, “said Permanent Secretary.
–
